Morgan Stanley Direct Lending Fund
NYSE:MSDLFinancial - Conglomerates
+$0.14 today
- Market cap
- $1.11B
- Beta
- 0.62
- P/E (TTM)
- 14.9
- EPS (TTM)
- $1.02
- Dividend yield
- 12.75%
Volume 0.45M
Average 0.67M
MSDL Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Morgan Stanley Direct Lending FundNYSE: MSDL
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables turns negative
Q1 FY2026 accounts receivables was -$3.3M, compared with $3.62M a year earlier. Trailing-twelve-month accounts receivables was -$8.04M.
Context
- Accounts receivables amounted to 1.1% of revenue in FY2025, up 0.6 pp from a year earlier.
- Accounts receivables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near -$3.3M or moves back toward the trailing-twelve-month quarterly average of -$2.01M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 4.22M USD
- Year-over-year change
- +352.8%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.22M | +352.8% |
| FY2024 | 2024-12-31 | (1.67M) | +79.1% |
| FY2023 | 2023-12-31 | (7.97M) | +13.1% |
| FY2022 | 2022-12-31 | (9.17M) | +3.1% |
| FY2021 | 2021-12-31 | (9.46M) | — |
Accounts Receivables vs competitors
How MSDL compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -434.2% is the lowest of 8, against a peer median of -34.6%.
- Accounts receivables amounts to 2.7% of revenue for MSDL, versus a peer median of 0.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Dec 2025 | CN¥370.6M CNY | -43.1% | -37.1% | 2.7% | |
| LTM Mar 2026 | $8.04M USD | -434.2% | — | 2.7% | |
| LTM Mar 2026 | $5.95M USD | +83.3% | — | 1.1% | |
| LTM Sep 2026 | $4.63M USD | +151.7% | -26.7% | 0.8% | |
| LTM Jun 2026 | $2.73M USD | -36.4% | -57.9% | 0.3% | |
| FY2026 | $2.49M USD | -34.6% | +9.5% | 0.6% | |
| FY2025 | $1.86M USD | +206.8% | — | 2.1% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | -71.8% | 0.0% | |
| LTM Jun 2025 | $0 USD | — | — | 0.0% | |
| LTM Dec 2025 | CN¥0 CNY | -100.0% | — | 0.0% | |
| Peer median (excluding MSDL) | — | -34.6% | -37.1% | 0.4% | |
Competitors are the stored peer set for MSDL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 83.26M | 48.54M | 231.01M | 215.56M | 122.09M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 3.14M | 2.43M | (695K) | 1.59M | 3.32M |
| Accounts Receivables | (9.46M) | (9.17M) | (7.97M) | (1.67M) | 4.22M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 6.78M | (64K) | 3.88M | 2.22M | 879K |
| Other Working Capital | 5.81M | 11.67M | 3.4M | 1.04M | (1.78M) |
| Other Non-Cash Items | (18.7M) | 70.62M | (44.54M) | (15.68M) | 25.48M |
| Operating Cash Flow | 67.69M | 121.59M | 185.78M | 201.47M | 150.9M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (2.11B) | (945.21M) | (632.1M) | (1.23B) | (771.59M) |
| Sales of Investments | 384.49M | 393.78M | 362.49M | 657.19M | 771.89M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (1.73B) | (551.43M) | (269.6M) | (575.01M) | 301K |
| Debt Repayment | 916M | 281.33M | (30M) | 467.45M | 105.35M |
| Common Stock Issued | 854.61M | 254.59M | 222.75M | 95.89M | (163K) |
| Common Stock Repurchased | 0 | 0 | 0 | (18.06M) | (42.13M) |
| Dividends Paid | (38.22M) | (85.75M) | (110.5M) | (169.08M) | (184.03M) |
| Other Financing Activities | (8.21M) | (13.27M) | (9.94M) | 0 | (12.09M) |
| Financing Cash Flow | 1.72B | 436.9M | 72.31M | 376.19M | (132.9M) |
| Effect of Forex Changes | 0 | 0 | 0 | 12K | 38K |
| Net Change in Cash | 62.89M | 7.06M | (11.51M) | 2.67M | 18.04M |
| Free Cash Flow | 67.69M | 121.59M | 185.78M | 201.47M | 150.9M |
Morgan Stanley Direct Lending Fund
NYSE:MSDL
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.